Tetroxoprim
![]() | |
| Clinical data | |
|---|---|
| ATC code | J01EE06 (WHO) (with sulfadiazine) |
| Identifiers | |
| |
| CAS Number |
53808-87-0 |
| PubChem (CID) | 65450 |
| ChemSpider |
58910 |
| UNII |
5R6712AY0K |
| KEGG |
D06097 |
| ChEMBL |
CHEMBL32039 |
| ECHA InfoCard | 100.053.427 |
| Chemical and physical data | |
| Formula | C16H22N4O4 |
| Molar mass | 334.70 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Tetroxoprim (INN) is a derivative of trimethoprim. It was first described in 1979.[1]
References
- ↑ Aschhoff HS, Vergin H (November 1979). "Tetroxoprim—a new inhibitor of bacterial dihydrofolate reductase". J Antimicrob Chemother. 5 (B): 19–25. doi:10.1093/jac/5.supplement_b.19. PMID 43863.
This article is issued from Wikipedia - version of the 5/25/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
